HD-OPM Archive
Topics › Blood pressure, salt & potassium

ARB blood pressure drugs such as losartan may lower cancer risk

Louis Nervegna · Feb 20, 2026 · ♥ 8 reactions · 3 comments · original Facebook post
Blood pressure, salt & potassiumCancer
AI summary & key facts

Louis notes ARBs like losartan, and possibly ACE inhibitors, may reduce cancer risk, based on a shared overview.

ARB blood pressure medications such as Losartan may reduce risk for cancer.

ACE inhibitors may also have a benefit.

#arbsHD #aceinhibitorsHD #losartanHD #cancerHD #bloodprrssureHD

Losartan (brand name: Cozaar) is a common oral medication that nearly every retail pharmacy carries. Since its FDA approval in 1995, losartan is most commonly used to treat high blood pressure in adults. It can also be used in children age 6 and older with high blood pressure. Losartan belongs to a class of medications known as angiotensin II receptor blockers, or ARBs. The American Heart Association guidelines name ARBs as a preferred first-line therapy for hypertension, making this a very widely used drug.

ARBs block the angiotensin II receptor as part of the renin-angiotensin system, or RAS. When present in excess, angiotensin II can cause blood vessel constriction and fluid retention, leading to elevated blood pressure. Beyond its circulatory effects, excessive angiotensin II may also contribute to endocrine, nervous system, and urinary complications. It is also thought that angiotensin II may help drive tumor growth. Losartan works by blocking angiotensin II from binding to its receptors.

Recent research suggests that at the local tissue level, the renin-angiotensin system may influence tumor growth and metastasis. Experimental studies provide evidence that drugs that inhibit RAS could potentially reduce cancer risk or slow tumor progression. Using losartan to manipulate this pathway may therefore represent a safe and inexpensive anticancer strategy.

Anticancer Mechanism #1: RAS Pathway
Losartan blocks angiotensin II from reaching its receptor in blood vessel muscles. This may disrupt cellular signaling that supports tumor progression. The RAS pathway has been implicated in tumor growth, cell proliferation, blood vessel formation, inflammation, and cell death. Inhibiting RAS with losartan may also alter tumor blood flow, potentially limiting the tumor’s ability to sustain itself.

Anticancer Mechanism #2: Inhibiting Collagen
Losartan may also reduce collagen deposition and maturation within tumors. Type I collagen is a structural protein found throughout the body. Interactions between tumor cells and collagen can promote abnormal cell growth and structural changes that support cancer progression. By reducing collagen content within tumors, losartan may disrupt this tumor-supporting environment and potentially limit cancer proliferation.

Anticancer Mechanism #3: Decreasing Microvessel Tumor Density
Losartan has also been shown to decrease transforming growth factor beta, or TGFβ1, a signaling protein involved in tumor progression and metastasis. By lowering TGFβ1 expression and activity, losartan may help reduce tumor growth, spread, and vascular complications.

Ovarian cancers often stop responding to chemotherapy, which is why researchers have explored additional treatment strategies. A 2018 study found that the use of ACE inhibitors or ARBs was associated with increased survival in patients with advanced-stage ovarian cancer.

In this retrospective analysis of patients treated between 2010 and 2014, investigators found that patients taking ACE inhibitors, such as lisinopril, or ARBs, such as losartan, had a significantly reduced risk of death compared to those taking other blood pressure medications. Women taking ACE inhibitors or ARBs had a median survival of 63 months, compared to 33 months for women taking other medications. The study also suggested that ARB treatment may be superior to ACE inhibitor treatment.

You can read more about losartan’s potential anticancer effects here:

AntiCancer360How a Common Generic Blood Pressure Drug May Combat Cancer: Exploring the Anticancer Potential of LosartanDuring cancer treatment, some people choose to use natural remedies and lifestyle changes alongside recommended oncology treatments. An additional popularanticancer360.com

And for a broader overview of our overall approach, you can watch our webinar here:

webinars.anticancer360.comFree Online Workshopwebinars.anticancer360.comNo photo description available.
← newer: Statin use linked to lower liver decompensation risk in primolder: IARC classifies processed meat as a Group 1 carcinogen, like →